NCT07816315: Phase 3 Study of Intravitreal OLN324 in Adults With Neovascular (Wet) Age-related Macular Degeneration (nAMD) (OLN324-CP-04)
- State
- Not started
- Phase
- Phase 3
- People
- 500 planned
- Started
- 15 Oct 2026
- Primary completion
- 15 Dec 2028
- Arms
- OLN324
- Results
- None posted
- 11 Sep 2026: Trial registered